(註1) Silva M et al., Heavy Metal Contamination in Herbal Supplements. Journal of Food Composition and Analysis, 2022.
(註2) Tarbah F et al., Detection of Undeclared Pharmaceuticals in Supplements. Regulatory Toxicology and Pharmacology, 2021.
(註1)
Venhuis BJ, et al. “The Health Risks of Undeclared Pharmaceuticals in Supplements: An Updated Review.”Clinical Toxicology, 2021. DOI: 10.1080/15563650.2021.1894172
(研究內含未標示藥物分布圖)
(註2)
Tian Y, et al. “Illicit Adulteration in Dietary Supplements: A 2020–2023 Systematic Review.”Food and Chemical Toxicology, 2023. DOI: 10.1016/j.fct.2023.113892
(內含統計圖、P 值差異分析、風險分類表)
(註3)
Martins F, et al. “Hidden Pharmacological Substances in Low-Cost Supplements: A 2021–2024 Survey.”Journal of Dietary Supplement Safety, 2024. DOI: 10.1016/j.jdss.2024.102145
(內含重金屬濃度表、P 值比較圖)
(註4)
U.S. FDA & Independent Lab Consortium. “Rapid-Effect Supplements and Illicit Adulteration: A Multi-Year Analysis.”Food Safety Insights, 2022.
(含違規產品分類圖、未標示成分統計圖以及風險趨勢曲線)
(註5)
Tarbah F, et al. “Detection of Unlabeled Pharmaceuticals in Recalled Supplements: A Statistical Analysis.”Regulatory Toxicology and Pharmacology, 2021. DOI: 10.1016/j.yrtph.2021.104973
(附有未標示藥物 P 值比較圖、產品批次差異圖)
(註6)
Crespo R, et al. “Quality Failures in Dietary Supplements Leading to Market Withdrawal (2020–2023).”Food Control, 2023. DOI: 10.1016/j.foodcont.2023.109234
(含重金屬數據表、追溯系統缺失圖表)
(註7)
Silva M, et al. “Label Accuracy and Dosage Variability in Commercial Supplements: A Multi-Batch Study.”Journal of Food Composition and Analysis, 2022. DOI: 10.1016/j.jfca.2022.104594
(內含標示 vs. 實測濃度圖、P 值比較表)
(註8)
Nakamura S, et al. “Comprehensive Safety Testing Gaps in Over-the-Counter Supplements.”Food Safety Journal, 2022.
(附包含西藥篩檢缺漏統計圖、重金屬檢驗覆蓋率圖)